Practical considerations such as injection frequency, needle size, and gastrointestinal tolerability may also influence individual patient selection
SUSTAIN-6 confirmed the non-inferiority of once weekly treatment with 0.5 or 1 mg of once weekly GLP-1RA semaglutide
Actually, technically, I think tomorrow would be that day, but it was very close
Enrollment by income Enrollment in 2025 marketplace plans made during the 2024-2025 open enrollment period
This stability lets BPC-157 stay active throughout the body, whether given orally, subcutaneously, intramuscularly, or topically
In a statement, Scott Brunner, CEO of the Alliance for Pharmacy Compounding, questioned whether the FDA's resolution of the shortage had taken into account demand for the compounded drug and "the number of patients wholl need to be transitioned from a compounded version to a FDA-approved version. "Thats likely hundreds of thousands of patients," Brunner said